For example, a small compound NSC59984 screened from National Cancer Institute (NCI; Bethesda, MD) induces the degradation of mutant p53 protein in human colon cancer cells SW480 via MDM2 and the ubiquitin-proteasome pathway [21]. This evidence concerns the gene TP53 and malignant colon neoplasm.